Condition: Type 1 Diabetes Mellitus · Type 1 Diabetes Mellitus (T1DM) · T1DM · Sponsor: Sultan Qaboos University
This is a multi-centre, prospective, randomized, open-label controlled trial designed to evaluate the effectiveness of a flexible digital insulin dose calculator in children under 12 years of age with Type 1 Diabetes Mellitus (T1DM) managed with multiple daily injections (MDI). Participants will be stratified by continuous glucose monitoring (CGM) use and baseline HbA1c, and randomised to receive either standard care alone or standard care plus the insulin dose calculator tool for 6 months. The primary outcome is the change in HbA1c from baseline to 6 months. Secondary outcomes include CGM-derived glycaemic metrics (Time in Range, Time Below Range, Time Above Range, and Coefficient of Variation), total daily insulin dose (units/kg/day), healthcare provider contact frequency, and caregiver-reported usability and satisfaction. The study aims to determine whether the use of a structured digital decision-support tool improves glycaemic control and supports safer insulin dosing in paediatric patients with T1DM.
This description comes directly from the study's public registry record.
Hussain Alsaffar, FACE, MSc, FRCPCH, CCT, MBChB · 0096896399402 · hussaina@squ.edu.om
Nandu Kumar Thalange, Professor · 00971589466920 · n.thalange@genesis-dubai.com
Always discuss trial participation with your own doctor first.
| University of Mosul | Mosul, Iraq | Recruiting |
| University Child Hospital | Lahore, Pakistan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07427134